| Ticker | SGEN |
|---|---|
| ISIN | US81181C1045 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with adv...
El precio actual de Seagen (SGEN) es de 228,74 , con una variación del -0,07%.
Seagen opera en el sector Healthcare, industria Biotechnology.